Softwr

APIs · head to head

i2c vs LatchBio

i2c logo

i2c

APIs

Configurable card issuing and banking processing platform for banks and programme managers

From
On request
Free plan
No
LatchBio logo

LatchBio

AI

AI agents that run bioinformatics analyses, from a company that pivoted from workflow hosting

From
On request
Free plan
No

The short version

  • Only i2c lists configurable product engine; only LatchBio lists agent driven analysis.
  • Prices and features on this page were last checked on 1 September 2026.

Where they differ

Only the attributes on which i2c and LatchBio actually diverge.

Attributes where i2c and LatchBio differ
Attributei2cLatchBio
PlatformsWeb, APIWeb
CategoryAPIsAI

Identical on both: starting price (On request), pricing model (Quote), free tier (No).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in i2c

  • Configurable product engine
  • Credit and instalments
  • Multi-currency
  • Fraud and risk tooling
  • Digital banking front ends
  • Global scheme connectivity

Only in LatchBio

  • Agent driven analysis
  • Multi assay support
  • Published benchmarks
  • White labelled portals
  • Common file format handling
  • Managed compute

What people use each for

The jobs each tool is most often brought in to do.

i2c

  • A bank wanting credit, debit and prepaid portfolios on one processor rather than threenot LatchBio
  • An issuer in a market where local scheme and currency support rules out US-centric processorsnot LatchBio
  • A programme manager launching instalment products without building a lending corenot LatchBio
  • A credit union replacing an ageing processor without writing custom code for product rulesnot LatchBio

LatchBio

  • A small biotech with sequencing data and no bioinformatician who needs a first pass differential expression or cell type annotation quicklynot i2c
  • An assay or kit vendor that wants to give customers an analysis portal under its own branding rather than shipping raw filesnot i2c
  • A wet lab scientist who wants to explore a dataset interactively before commissioning a formal analysis from a core facilitynot i2c
  • A research group benchmarking agent produced analyses against its own established pipeline to decide how much routine work can be delegatednot i2c

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

i2c

  • Developer experience lags API-native competitors, and teams expecting Stripe-grade documentation and sandboxes find an enterprise integration project instead
  • Implementations lean on i2c or partner professional services, so timelines and costs are set by a services queue rather than by your own engineering speed
  • Pricing is per active card and per transaction with monthly minimums, none of it published, so comparing bids requires modelling your own portfolio carefully
  • Configuration flexibility means product behaviour lives in platform settings rather than in your repository, which complicates version control, testing and audit trails
  • As a private company with a broad global footprint, regional support depth is uneven, and a programme in a smaller market may get thinner service than a flagship account

LatchBio

  • The company has pivoted from hosted bioinformatics workflows to AI agents, so organisations that adopted the earlier SDK and workflow product are now on a line that is no longer the strategic focus
  • Agent generated analysis code has to be validated by someone who could have written it, which inverts the value proposition for the small labs that most need it and cannot check the output
  • No pricing is published, so the cost of routine agent analysis at team scale cannot be estimated without contacting sales, and compute billed through the platform makes the bill usage dependent
  • Regulated use is a poor fit: an agent that writes non deterministic analysis code is difficult to validate under GxP, so this is a research tool rather than something that will sit in a regulated diagnostic or submission workflow
  • The vendor publishes its own benchmarks, which is more than most competitors do, but self reported benchmarks on selected datasets are not a substitute for testing the agent on your own data before committing

Pricing, plan by plan

i2c

On request
  • i2c processing platformOn request
    • Per-active-card and per-transaction processing fees
    • Minimum monthly commitments by programme
    • Implementation and configuration professional services

LatchBio

On request
  • LatchBio PlatformOn request
    • Quoted through a sales process
    • Interactive sandbox available for trying the agent before contracting
    • Enterprise and white labelled portal deployments priced separately

Which should you pick?

Choose i2c if

  • You need configurable product engine.
  • You work on Web, API.
  • You also want credit and instalments.

Choose LatchBio if

  • You need agent driven analysis.
  • You also want multi assay support.

Questions people ask

Is i2c or LatchBio better?
Neither clearly leads. i2c starts at On request and LatchBio at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, i2c or LatchBio?
i2c starts at On request and LatchBio at On request.
Does i2c or LatchBio run on more platforms?
i2c runs on Web, API. LatchBio runs on Web.
What is i2c best used for?
i2c is most often used for a bank wanting credit, debit and prepaid portfolios on one processor rather than three, an issuer in a market where local scheme and currency support rules out us-centric processors, a programme manager launching instalment products without building a lending core, a credit union replacing an ageing processor without writing custom code for product rules. Of those, a bank wanting credit, debit and prepaid portfolios on one processor rather than three and an issuer in a market where local scheme and currency support rules out us-centric processors are not what LatchBio is typically brought in for.
What can i2c do that LatchBio cannot?
i2c covers Configurable product engine, Credit and instalments, Multi-currency, Fraud and risk tooling. LatchBio covers Agent driven analysis, Multi assay support, Published benchmarks, White labelled portals.

Answered from the vendors’ own pages

i2c: Does i2c issue the cards itself?

No. It processes; issuance sits with a bank or licensed issuer, and in most markets you need that relationship separately.

LatchBio: Is LatchBio still selling the original workflow platform?

The company is now led by agent.bio and its agent products. Buyers evaluating the older Python SDK workflow platform should confirm current support directly.

i2c: Can it handle revolving credit?

Yes. Credit, instalments and buy-now-pay-later sit on the same platform as debit and prepaid, which is unusual among modern processors.

LatchBio: Can I try it before buying?

Yes. There is an interactive sandbox where you can upload data and run the agent before entering a sales conversation.

i2c: Is it self-serve?

No. Expect a configuration-led implementation with professional services rather than signing up and calling an API.

LatchBio: Is it suitable for regulated work?

Not really. Non deterministic agent generated code is hard to validate under GxP, so treat it as a research and exploration tool.

LatchBio: What data types does it handle?

Single cell RNA sequencing, spatial transcriptomics, epigenomics, proteomics and pharmacology data, ingesting FastQ, H5AD and spreadsheet formats.

Share

Related pages

Other head to heads